Gthx analyst
WebMay 7, 2024 · GTHX earnings call for the period ending March 31, 2024. ... Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources ... WebGTHX Complete G1 Therapeutics Inc. stock news by MarketWatch. View real-time …
Gthx analyst
Did you know?
WebAug 4, 2024 · Our total revenue for the second quarter of 2024 was $10.6 million, comprised of net Cosela revenue of $8.7 million and license revenue of $1.9 million compared to $6.6 million of total revenue ... WebAug 24, 2024 · The average price target is $51.833, which means analysts expect the stock to rise by 267.09% over the next twelve months. That average ranking earns GTHX an Analyst Rating of 64, which is better than 64% of stocks based on data compiled by InvestorsObserver . Wall Street analysts are rating GTHX a Strong Buy today.
WebLearn to value G1 Therapeutics, Inc. (GTHX) stock with easy-to-understand analysis. From popular relative valuation methods to future cashflows and analyst forecasts. ... The above table shows the analyst GTHX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y ... WebAug 24, 2024 · The average price target is $51.833, which means analysts expect the …
WebApr 6, 2024 · View GTHX revenue estimates and earnings estimates, as well as in-depth … WebApr 11, 2024 · RESEARCH TRIANGLE PARK, N.C., April 11, 2024 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Executive Officer Jack Bailey and other members of the Executive Team will participate in a fireside chat during the 22nd Annual Needham …
WebMar 24, 2024 · The stock is rated as a Hold by 1 analyst(s), 6 recommend it as a Buy and 1 called the GTHX stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Buy.
WebSee G1 Therapeutics, Inc. (GTHX) stock analyst estimates, including earnings and … Find out the direct holders, institutional holders and mutual fund holders for G1 … See the company profile for G1 Therapeutics, Inc. (GTHX) including … Find the latest G1 Therapeutics, Inc. (GTHX) stock discussion in Yahoo … Discover historical prices for GTHX stock on Yahoo Finance. View daily, weekly or … hyundai h1 spares for sale in gautengWebApr 12, 2024 · G1 Therapeutics (GTHX) has been upgraded to a Zacks Rank #2 (Buy), … hyundai h1 for sale west randWebBased on analysts offering 12 month price targets for GTHX in the last 3 months. The … hyundai h1 high roofWebApr 6, 2024 · Get the latest G1 Therapeutics GTHX detailed stock quotes, stock data, … molly gregory editorWebApr 11, 2024 · RESEARCH TRIANGLE PARK, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. GTHX, a commercial-stage oncology company, today announced that G1's Chief Executive Officer Jack Bailey and ... hyundai h1 pricesWebApr 10, 2024 · Stock Price Forecast. According to 14 stock analysts, the average 12-month stock price forecast for GTHX stock is $ 14.11 , which predicts an increase of 322.46%. The lowest target is $ 5.05 and the highest is $ 25.2. On average, analysts rate GTHX stock as … hyundai h1 starex crdiWebG1 Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & … hyundai h1 occasion le bon coin